Where Does Emergent Biosolutions Inc (EBS) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Fallen -12.29% This Week?

Emergent Biosolutions Inc (EBS) is near the middle in its industry group according to InvestorsObserver. EBS gets an overall rating of 43. That means it scores higher than 43 percent of stocks. Emergent Biosolutions Inc gets a 57 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 99 out of 148 industries.

EBS has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on EBS!

See Full EBS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 43 means the stock is more attractive than 43 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Emergent Biosolutions Inc Stock Today?

Emergent Biosolutions Inc (EBS) stock is trading at $2.07 as of 1:22 PM on Tuesday, Nov 14, a gain of $0.25, or 13.74% from the previous closing price of $1.82. The stock has traded between $1.85 and $2.16 so far today. Volume today is less active than usual. So far 1,031,905 shares have traded compared to average volume of 1,435,342 shares. Click Here to get the full Stock Report for Emergent Biosolutions Inc stock.